APA (7th ed.) Citation

Shin, S. H., Park, Y., Park, S. S., Ju, E. J., Park, J., Ko, E. J., . . . Choi, E. K. (2021). An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate against Refractory HER2‐Positive Cancers. Advanced Science, 8(23), 1. https://doi.org/10.1002/advs.202102414

Chicago Style (17th ed.) Citation

Shin, Seol Hwa, et al. "An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate Against Refractory HER2‐Positive Cancers." Advanced Science 8, no. 23 (2021): 1. https://doi.org/10.1002/advs.202102414.

MLA (9th ed.) Citation

Shin, Seol Hwa, et al. "An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate Against Refractory HER2‐Positive Cancers." Advanced Science, vol. 8, no. 23, 2021, p. 1, https://doi.org/10.1002/advs.202102414.